Showing 1921-1930 of 7024 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20409/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20614/Acquired Cutis Laxa: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/acquired-cutis-laxa-a-case-report/23653/Treatment of Demodicosis with Potassium Hydroxide Dermabrasion
https://practicaldermatology.com/youngmd-connect/resident-resource-center/treatment-of-demodicosis-with-potassium-hydroxide-dermabrasion/23703/New in My Practice: Rx/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rxnew-products/23522/Reversing Cicatricial Ectropion Related to Chronic Periocular Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/reversing-cicatricial-ectropion-related-to-chronic-periocular-atopic-dermatitis/23752/Case Report: Pityriasis Versicolor: Using the Wood's Lamp in Diagnosis; Residents of Distinction Honored
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-pityriasis-versicolor-using-the-woods-lamp-in-diagnosis-residents-of-distinction-honored/21011/Pipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.Improving Your After-Tax Financial Efficiency
https://practicaldermatology.com/topics/practice-management/improving-your-after-tax-financial-efficiency/20587/Two strategies for recapturing dollars left on the table.Dupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/